[ad_1]
France, through its anti-drug agency (ANSM), issued a statement in the last few hours asking the European Union to carry out studies to badess the risks and benefits of products containing two types of drugs. . the last time your consumption has increased.
It is ibuprofen and ketoprofen, both substances placed under the control of French specialists because of the risk involved in the use of drugs, as they could even worsen the infections that They intend to treat.
Product of the study, the ANSM published a series of recommendations for consumers, in which it asks to privilege the use of paracetamol before ibuprofen and ketoprofen in case of fever or pain, in particular when it comes to an infection such as angina, nasopharyngitis, cough, lung infection, as well as for a skin lesion or chickenpox, according to the EFE news agency.
He also recommended to use "the minimal effective dose, for the shortest duration", to discontinue treatment when symptoms disappear and not to prolong it for more than three days in case of fever, or more than five days in case of pain.
This series of recommendations comes from a study carried out in June 2018 in its regional centers of Tours and Marseille, which concluded to the existence of a number of infections, particularly in France. streptococci, which could be aggravated by taking these two drugs.
Complications would have occurred after short periods of treatment, when the drugs had been used to treat fever, mild skin problems of inflammation, respiratory disorders or otolaryngology.
The study was conducted over a prolonged period during which French scientists badyzed 337 infectious complications related to ibuprofen and 49 to severe ketoprofen, leading to hospitalizations , after-effects and even death.
.
[ad_2]
Source link